Search Results - "Nash, Andrew D."

Refine Results
  1. 1
  2. 2

    HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure by Ow, Saw Yen, Kapp, Eugene A, Tomasetig, Vesna, Zalewski, Anton, Simmonds, Jason, Panousis, Con, Wilson, Michael J, Nash, Andrew D, Pelzing, Matthias

    Published in mAbs (2023)
    “…Hageman factor (FXII) is an essential component in the intrinsic coagulation cascade and a therapeutic target for the prophylactic treatment of hereditary…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus by Oon, Shereen, Monaghan, Katherine, Ng, Milica, Hoi, Alberta, Morand, Eric, Vairo, Gino, Maraskovsky, Eugene, Nash, Andrew D, Wicks, Ian P, Wilson, Nicholas J

    “…Objectives Plasmacytoid dendritic cells (pDCs), through the production of type 1 interferons (IFNs) and other cytokines, are major contributors to systemic…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    An Anti-VEGF-B Antibody Fragment Induces Regression of Pre-Existing Blood Vessels in the Rat Cornea by Irani, Yazad D, Scotney, Pierre D, Klebe, Sonja, Mortimer, Lauren A, Nash, Andrew D, Williams, Keryn A

    “…We tested the ability of an antibody fragment with specificity for vascular endothelial growth factor-B (VEGF-B) to regress nascent and established corneal…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus by Oon, Shereen, Huynh, Huy, Tai, Tsin Yee, Ng, Milica, Monaghan, Katherine, Biondo, Mark, Vairo, Gino, Maraskovsky, Eugene, Nash, Andrew D, Wicks, Ian P, Wilson, Nicholas J

    Published in JCI insight (05-05-2016)
    “…To date, the major target of biologic therapeutics in systemic lupus erythematosus (SLE) has been the B cell, which produces pathogenic autoantibodies…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The biology of vascular endothelial growth factor-B (VEGF-B) by Nash, Andrew D., Baca, Manuel, Wright, Christine, Scotney, Pierre D.

    Published in Pulmonary pharmacology & therapeutics (01-01-2006)
    “…The formation of new blood vessels (angiogenesis) is critical for both embryonic development and a variety of normal postnatal physiological processes. Various…”
    Get full text
    Journal Article
  17. 17

    Crystal Structure of Human Vascular Endothelial Growth Factor-B: Identification of Amino Acids Important for Receptor Binding by Iyer, Shalini, Scotney, Pierre D., Nash, Andrew D., Ravi Acharya, K.

    Published in Journal of molecular biology (26-05-2006)
    “…The development of blood vessels (angiogenesis) is critical throughout embryogenesis and in some normal postnatal physiological processes. Pathological…”
    Get full text
    Journal Article
  18. 18

    Crystal Structure of Vascular Endothelial Growth Factor-B in Complex with a Neutralising Antibody Fab Fragment by Leonard, Philip, Scotney, Pierre D., Jabeen, Talat, Iyer, Shalini, Fabri, Louis J., Nash, Andrew D., Acharya, K. Ravi

    Published in Journal of molecular biology (31-12-2008)
    “…Vascular endothelial growth factor (VEGF) B effects blood vessel formation by binding to VEGF receptor 1. To study the specifics of the biological profile of…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Towards a Structure-Function Relationship for Vascular Endothelial Growth Factor-B (VEGF-B) by Scrofani, Sergio D.B, Nash, Andrew D

    “…The vascular endothelial growth factor (VEGF), or VEGF-A, is intimately involved in both physiological and pathological forms of angiogenesis. VEGF-A is now…”
    Get full text
    Journal Article